We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cancer Detection Rates for Digital Mammography May Differ Considerably

By HospiMedica International staff writers
Posted on 30 May 2013
Digital direct radiography (DR) has been shown to be substantially more effective than computed radiography (CR) at detecting breast cancer.

The findings, published online May 14, 2013, in the journal Radiology are the first to show a difference between the two types of digital imaging when compared with screen film mammography, and suggest that women should be notified of the potential for lower cancer detection with CR, according to the researchers. More...


Digital mammography, which involves capturing an electronic image of the breast that can be stored and sent electronically, has recently replaced screen film mammography. CR and DR are the two types of digital mammography offered. DR is an online system in which the detector is an integral part of the mammographic unit, and the digital image can be read by the system in real time. CR is an offline system that depends on a cassette-based removable detector. An external reading device is used to generate the digital image.

Whereas many studies have been published comparing digital mammography with screen film mammography, less is known about the comparative effectiveness of DR and CR, according to Anna M. Chiarelli, PhD, senior scientist from the Prevention and Cancer Control at Cancer Care Ontario (Toronto, Canada). “Digital mammography was implemented progressively in Ontario starting in 2006, and since that time there’s been no evidence in the literature to suggest that CR did not perform as well as DR,” she said.

For the new study, Dr. Chiarelli and colleagues drew upon data from the Ontario Breast Screening Program (OBSP), initiated in 1990 to deliver breast screening to women between the ages of 50 and 74. The researchers identified three groups of women 50 to 74 years old who were screened between January 1, 2008, and December 31, 2009. A total of 403,688 women were screened by screen film mammography, while 220,520 had DR and 64,210 underwent CR. The women were followed for 12 months after screening.

DR detected 4.9 tumors per 1,000 mammograms, a figure almost identical to screen film mammography’s rate of 4.8 cancers per 1,000 mammograms. However, CR’s detection rate of 3.4 tumors per 1,000 mammograms was significantly lower. “CR was 21% less effective than DR,” Dr. Chiarelli said. “This could result in about 10 fewer cancers detected per 10,000 women screened.”

The reason for the lower detection rates in all probability can be ascribed to technical factors, Dr. Chiarelli added. “There may be several technical reasons reported by others for the lower effectiveness of CR, including loss of spatial resolution, or sharpness, and increased image noise, or granularity,” she said.

Dr. Chiarelli noted that the new findings hold more weight than those of earlier studies because of the larger number of women screened and the reliance on concurrent cohorts, or different groups followed over the same period.

Related Links:
Prevention and Cancer Control at Cancer Care Ontario



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Preoperative Skin Preparation
BD ChloraPrep
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.